SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression

BACKGROUND: The multiple tyrosine kinase inhibitors SU6668 have a promising therapeutic effect on the progression of hematological malignancies and some solid tumors. Here, we determined its effect on triple negative breast cancer (TNBC) cells and explored the potential molecular mechanism. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Liu, Zhaozhe, Ma, Dongchu, Piao, Ying, Guo, Fang, Han, Yaling, Xie, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844503/
https://www.ncbi.nlm.nih.gov/pubmed/23984913
http://dx.doi.org/10.1186/1475-2867-13-88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844503/
https://www.ncbi.nlm.nih.gov/pubmed/23984913
http://dx.doi.org/10.1186/1475-2867-13-88

Ejemplares similares